Is the NZ Herald’s new editorial mission an example of cheerleading for one side of politics or just a move to cheer us all ...

Investors keep bidding up growth companies, so it is up to boards to work out how to capitalise. Do they want an easy life on ...

The consequences for investors are less beneficial. The proliferation of quasipassive funds adds to the overwhelming array of ...

The Brink's Company maintains strong growth in AMS and DRS segments. Read why BCO stock is a buy with double-digit growth and ...

This Artificial Intelligence (AI) Stock Has Delivered Bigger Gains Than Nvidia. It Could Soar Another 77%.

The push forward with digital ID initiatives reflects a broader movement toward integrating digital identities into daily ...

The Revolve Group has carved out an interesting competitive niche in the affordable luxury category, leaning heavily into the strengths of the e-commerce channel—breadth of selection, scalability, and ...

Enterprise revenue grew 6% year over year and now comprises 60% of total revenue. The company secured a notable enterprise win with Amazon (NASDAQ: AMZN), marking a transition from Amazon's previous ...

The stock market is luring investors with promises. Here's why they should be nervous. The S&P 500's false upside breakouts should give stock buyers pause. Read More Value investor Bill Nygren ...

Sigma Planning Corp reduced its stake in shares of Invesco S&P MidCap Value with Momentum ETF (NYSEARCA:XMVM – Free Report) by 17.0% in the fourth quarter, Holdings Channel.com reports. The ...

Learn more about whether Haemonetics Corporation or iRhythm Technologies, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Salesforce is talking down the potential sales 2025 impact of its AI agents after its earnings release. The software giant's stock dropped nearly 5% to $292.80 in premarket tradin ...